EGFR and lung adenocarcinoma: We performed this retrospective study to eliminate the impact of potential confounding factors on the results to explore the necessity of craniocerebral radiotherapy for EGFR-mutant lung adenocarcinoma patients with brain metastases used propensity score matching (PSM).